OR9I1

Across TCGA pan-cancer cohorts, OR9I1 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated OR9I1 data layer compared with 3 for mutation status.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher OR9I1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR9I1 expression acts as an unfavorable survival marker, although some lineages such as ESCA and STAD show a favorable association.

UCEC, COAD, and BLCA are the cancer types where OR9I1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Tertile	All	0.311	0.687	<.001	108	view →
COAD	OS	Tertile	IV	0.089	0.676	<.001	72	view →
BLCA	DFS	Tertile	III,IV	0.225	0.555	<.001	45	view →
THCA	DFS	Tertile	II,III,IV	0.100	0.763	<.001	36	view →
LUSC	OS	Tertile	III,IV	0.047	0.684	<.001	36	view →
LIHC	DFS	Tertile	All	0.330	0.550	.022	24	view →
ESCA	OS	Tertile	III,IV	0.654	0.364	.037	18	view →
GBM	DFS	Tertile	All	0.068	0.288	.003	9	view →
STAD	OS	Tertile	IV	1.000	0.299	.047	6	view →
KIRC	DFS	Tertile	All	0.901	0.861	.027	5	view →
HNSC	OS	Tertile	IV	0.541	0.316	.029	3	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

OR9I1–UCEC (OS)

Open the UCEC breakdown →